Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2965493 | Journal of Cardiovascular Disease Research | 2012 | 10 Pages |
Abstract
Cardiac embolism, primarily from atrial fibrillation (AF), is implicated in a quarter of all ischemic strokes. In the setting of AF, contraindications to traditional therapies can create a clinical dilemma when choosing an agent for secondary stroke prophylaxis. Newer horizons in the medical and surgical management of AF have helped us choose from a wide variety of available therapies, the best possible management. In this article, we review the current trends in AF management including newer oral anticoagulants as well as surgical devices from a neurologist's view.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Vishnumurthy Shushrutha Hedna, Christopher G. Favilla, Waldo R. Guerrero, Akhil Patel, Amareshwari Gottipati, Michael F. Waters, Sharathchandra Bidari, Beaver Thomas,